This protocol is judged by an institutional evaluate board, an impartial group that assessments any clinical trials involving human beings. If a analyze includes a Program I drug, when the board approves the protocol as moral, the researchers should submit an application for an investigational new drug (IND) range within the FDA.Fortunately, other